IMS Health CEO Awarded $23.5 Million in Shares, Topping Peers

  • Executive gets outsized stock grant for second year running
  • Bousbib earns more than total pay for Pfizer, Lilly chiefs

IMS Health Holdings Inc., which tracks medical prescriptions and sells the data, paid its chief executive officer a $23.5 million stock award, more than the entire pay packages for the heads of much larger drug companies such as Pfizer Inc. and Eli Lilly & Co.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.